(VIANEWS) – ELIS (ELIS.PA), SPBK1 HELGELAND (HELG.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 5.03% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.86.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 20.55. Meaning, the purchaser of the share is investing €20.55 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.03%.
Volume
Today’s last reported volume for ELIS is 43252 which is 88.86% below its average volume of 388431.
Revenue Growth
Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 3.46B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 25, 2022, the estimated forward annual dividend rate is 0.37 and the estimated forward annual dividend yield is 2.23%.
More news about ELIS.
2. SPBK1 HELGELAND (HELG.OL)
28.7% sales growth and 9.31% return on equity
SpareBank 1 Helgeland provides various financial products and services to retail customers, small and medium enterprises, municipal authorities, and institutions in Norway. The company operates in two segments, Retail Market and Corporate Market. It offers savings, investment, and insurance products, as well as leasing and mortgage services. The company is also involved in owning, managing, and letting commercial properties. It operates through branches located in Mosjøen, Brønnøysund, and Sandnessjøen. The company was founded in 1860 and is headquartered in Mo i Rana, Norway.
Earnings Per Share
As for profitability, SPBK1 HELGELAND has a trailing twelve months EPS of kr12.8.
PE Ratio
SPBK1 HELGELAND has a trailing twelve months price to earnings ratio of 9.92. Meaning, the purchaser of the share is investing kr9.92 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.
Moving Average
SPBK1 HELGELAND’s value is under its 50-day moving average of kr130.22 and above its 200-day moving average of kr119.58.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 30, 2023, the estimated forward annual dividend rate is 10.26 and the estimated forward annual dividend yield is 8.08%.
Sales Growth
SPBK1 HELGELAND’s sales growth is 24.9% for the current quarter and 28.7% for the next.
More news about SPBK1 HELGELAND.
3. MONTEA (MONT.BR)
25.8% sales growth and 17.64% return on equity
Montea is a developing investor in logistics real estate in Belgium, France, Germany and the Netherlands. Our team of passionate specialists creates the ideal real estate solution together with the customer.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €12.27.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 6.24. Meaning, the purchaser of the share is investing €6.24 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.64%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 111.01M for the twelve trailing months.
More news about MONTEA.
4. BOIRON (BOI.PA)
17.3% sales growth and 8.13% return on equity
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.89.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 13.91. Meaning, the purchaser of the share is investing €13.91 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.
Sales Growth
BOIRON’s sales growth is 17.3% for the ongoing quarter and 17.3% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 1, 2023, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 2.84%.
Volume
Today’s last reported volume for BOIRON is 2493 which is 65.03% below its average volume of 7129.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 534.24M for the twelve trailing months.
More news about BOIRON.
5. FRØY (FROY.OL)
14% sales growth and 10.16% return on equity
Frøy ASA provides integrated service to the aquaculture industry in Norway. The company offers wellboat services, sea freight, de-lice and treatment, mooring and laying, ring washing and cage services, net washing and mending, inspection and certification, bottom mapping and documentation, slep, diving and ROV, and control system. It owns and operates 18 wellboats, 60 aqua service vessels, 3 feed transport vessels, and 13 local offices along the Norwegian coast. The company was founded in 2019 and is headquartered in Sistranda, Norway.
Earnings Per Share
As for profitability, FRØY has a trailing twelve months EPS of kr4.72.
PE Ratio
FRØY has a trailing twelve months price to earnings ratio of 14.15. Meaning, the purchaser of the share is investing kr14.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.16%.
Volume
Today’s last reported volume for FRØY is 33047 which is 79.35% below its average volume of 160068.
Yearly Top and Bottom Value
FRØY’s stock is valued at kr66.80 at 22:20 EST, below its 52-week high of kr68.00 and way higher than its 52-week low of kr31.70.
Sales Growth
FRØY’s sales growth is 18.9% for the ongoing quarter and 14% for the next.
More news about FRØY.
6. WALLENIUS WILHELMS (WAWI.OL)
12.4% sales growth and 21.73% return on equity
Wallenius Wilhelmsen ASA, together with its subsidiaries, transports and handle cars, tractors, trains, and windmills. It operates through three segments: Shipping Services, Logistics Services, and Government Services. The company provides liner services through a fleet of modern and versatile RoRo vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. In addition, it offers inland transportation services, as well as operates vehicle and equipment processing centres and inland distribution networks. The company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. It operates approximately 125 vessels servicing 15 trade routes. The company was founded in 1861 and is based in Lysaker, Norway.
Earnings Per Share
As for profitability, WALLENIUS WILHELMS has a trailing twelve months EPS of kr17.08.
PE Ratio
WALLENIUS WILHELMS has a trailing twelve months price to earnings ratio of 4.61. Meaning, the purchaser of the share is investing kr4.61 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.73%.
Yearly Top and Bottom Value
WALLENIUS WILHELMS’s stock is valued at kr78.75 at 22:20 EST, way under its 52-week high of kr103.00 and way above its 52-week low of kr47.60.
Moving Average
WALLENIUS WILHELMS’s value is below its 50-day moving average of kr86.64 and above its 200-day moving average of kr75.42.
More news about WALLENIUS WILHELMS.
7. ITERA (ITERA.OL)
11.2% sales growth and 138.07% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.54.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 24.72. Meaning, the purchaser of the share is investing kr24.72 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.
Volume
Today’s last reported volume for ITERA is 665 which is 97.31% below its average volume of 24731.
Yearly Top and Bottom Value
ITERA’s stock is valued at kr13.35 at 22:20 EST, below its 52-week high of kr14.50 and way above its 52-week low of kr10.50.
More news about ITERA.
8. MEDISTIM (MEDI.OL)
10.2% sales growth and 33.83% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr5.9.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 46.95. Meaning, the purchaser of the share is investing kr46.95 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.83%.
More news about MEDISTIM.
